<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>decentralized cancer treatment &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/decentralized-cancer-treatment/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sat, 06 Sep 2025 08:39:46 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>decentralized cancer treatment &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Bar-Ilan University Partners in €8 Million European Consortium to Accelerate and Enhance CAR-T Cancer Therapy Accessibility and Safety</title>
		<link>https://bioengineer.org/bar-ilan-university-partners-in-e8-million-european-consortium-to-accelerate-and-enhance-car-t-cancer-therapy-accessibility-and-safety/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 26 Aug 2025 15:40:39 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[automated CAR-T production]]></category>
		<category><![CDATA[CAR-T cell therapy accessibility]]></category>
		<category><![CDATA[CAR-T therapy automation]]></category>
		<category><![CDATA[CRISPR genome editing]]></category>
		<category><![CDATA[CRISPR genome editing safety]]></category>
		<category><![CDATA[decentralized cancer immunotherapy]]></category>
		<category><![CDATA[decentralized cancer treatment]]></category>
		<category><![CDATA[EASYGEN European consortium]]></category>
		<category><![CDATA[EASYGEN initiative]]></category>
		<category><![CDATA[personalized cancer treatment innovation]]></category>
		<guid isPermaLink="false">https://bioengineer.org/bar-ilan-university-partners-in-e8-million-european-consortium-to-accelerate-and-enhance-car-t-cancer-therapy-accessibility-and-safety/</guid>

					<description><![CDATA[Bar-Ilan University has recently become a central figure in an ambitious new European initiative that aims to dramatically transform the landscape of personalized cancer treatment. The initiative, backed by an €8 million investment from the Innovative Health Initiative (IHI), is called EASYGEN, a five-year project poised to revolutionize the production and delivery of CAR-T cell [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">258090</post-id>	</item>
	</channel>
</rss>
